Have a personal or library account? Click to login
Inhibitory effect of taspine derivative TAD1822-7 on tumor cell growth and angiogenesis via suppression of EphrinB2 and related signaling pathways Cover

Inhibitory effect of taspine derivative TAD1822-7 on tumor cell growth and angiogenesis via suppression of EphrinB2 and related signaling pathways

Acta Pharmaceutica
Volume 69 (2019): Issue 3 (September 2019)
By: Rui Liu,  Runze Yu,  Yuxin Cui,  Mengying Fan,  Bo Wang and  Yanmin Zhang  
Open Access
|Jun 2019

Authors

Rui Liu

School of Pharmacy, Xi’an Jiaotong University, Xi’an, China

Runze Yu

School of Pharmacy, Xi’an Jiaotong University, Xi’an, China

Yuxin Cui

School of Pharmacy, Xi’an Jiaotong University, Xi’an, China

Mengying Fan

School of Pharmacy, Xi’an Jiaotong University, Xi’an, China

Bo Wang

School of Pharmacy, Xi’an Jiaotong University, Xi’an, China

Yanmin Zhang

zhang2008@mail.xjtu.edu.cn

School of Pharmacy, Xi’an Jiaotong University, Xi’an, China
DOI: https://doi.org/10.2478/acph-2019-0021 | Journal eISSN: 1846-9558 | Journal ISSN: 1330-0075
Journal RSS Feed
Language: English
Page range: 423 - 431
Accepted on: Dec 3, 2018
|
Published on: Jun 26, 2019
Published by: Croatian Pharmaceutical Society
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year
Keywords:
TAD1822-7,
EphrinB2,
Bel-7402 cells,
proliferation,
migration,
anti-angiogenesis
Related subjects:
Pharmacy,
Pharmacy, other

© 2019 Rui Liu, Runze Yu, Yuxin Cui, Mengying Fan, Bo Wang, Yanmin Zhang, published by Croatian Pharmaceutical Society
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.

Previous articleVolume 69 (2019): Issue 3 (September 2019)Next article